... hair loss, it is not as effective and thus, it may be unfit for patients with alopecia totalis and alopecia universals. hassielramirezm@gmail.com 22 03 2023 1 09 2023 3 11 2023 © 2023 S. Karger AG, Basel Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved...

...Noelle Desir; Amar D. Desai; Shari R. Lipner Introduction: Androgenetic alopecia (AGA) is the most common form of hair loss, with negative impact on patient quality of life. Oral minoxidil is used off-label for AGA treatment. We hypothesized increased public interest in oral minoxidil for hair loss...

... to treat LPP, FFA, and AA. For all three conditions, HCQ showed variable efficacy from halted hair loss to no improvement. While patients did show success with HCQ treatment, there were no clear treatment patterns. Regimens ranged from HCQ monotherapy to combination treatments with other agents like...

...Hanna Englander; Briana Paiewonsky; Leslie Castelo-Soccio Alopecia areata (AA) is an autoimmune form of non-scarring hair loss that occurs on a spectrum from patchy loss of hair on the scalp, to complete hair loss. Histology features can vary, but increased abundance of telogen hair...

...Maria Fernanda Reis Gavazzoni Dias; Amanda Lofeu Cury; Enoi Aparecida Guedes Vilar; Patricia Guimarães Peixoto; Chloe Ekelem Introduction: Frontal Fibrosing Alopecia (FFA) and Fibrosing Alopecia in a Pattern Distribution (FAPD) are two distinct entities of cicatricial pattern hair loss that share...

...Lucia Genco; Mariateresa Cantelli; Matteo Noto; Teresa Battista; Angela Patrì; Gabriella Fabbrocini; Maria Vastarella Introduction: Alopecia areata (AA) is a common autoimmune disease characterized by non-scarring hair loss. New onsets of AA have been associated with coronavirus disease 2019 (COVID...

...Rita Fernanda Cortez de Almeida; Daniel Fernandes Melo; Antonella Tosti Scalp microinfusion is a promising novel drug delivery technique for hair loss treatment. We discuss the MMP® technique and review its possible use in alopecias. MMP® technique provides a small amount of drugs delivered...

...Ahmed Hassan Nouh; Ahmed Mohamed Abdelaal; Ali El Sayed Fathy Introduction: Alopecia areata is a common recurrent T cell-mediated autoimmune-induced non-scarring hair loss with not fully understood pathogenesis. It affects nearly 2% of the general population during lifetime. The course...

...Laita Bokhari; Phoebe Cottle; Ramon Grimalt; Michal Kasprzak; Justyna Sicińska; Rodney Sinclair; Antonella Tosti Introduction: Precise evaluation of changes in hair count is crucial for monitoring progression of hair loss and the effects of treatment. The focus of this study is the comparison...

..., quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Alopecia Hair cosmetics Hair histopathology Hair loss Micropigmentation...

...: “botulinum toxin” or “botox” and “androgenetic alopecia,” “hair loss,” or “alopecia.” Five clinical studies met our inclusion criteria: 4 prospective cohorts and 1 randomized clinical trial (RCT). Study durations ranged from 24 to 60 weeks. No studies included control groups or compared botulinum toxin...

..., quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Birbeck granules Hair loss Langerhans cell histiocytosis Tumor A 30...

... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Alopecia Biopsy Hair loss Horizontal section Transverse section Alopecia is a common and distressing clinical problem with many heterogeneous etiologies [1-3...

... , Nikkels-Tassoudji   N , Nikkels   AF . Hair loss after varicella zoster virus infection . Case Rep Dermatol . 2013 ; 5 ( 1 ): 43 – 7 . 10.1159/000348648 . 11. Chen   CH , Wang   KH , Hung   SH , Lin   HC , Tsai   MC , Chung   SD . Association between herpes zoster...

... reports have focused on telogen effluvium (TE) as a possible sequela of COVID-19. We assessed 14 cases of hair loss occurring after SARS-CoV-2 infection using trichoscopy and trichogram to investigate patterns related to COVID-19. Furthermore, we discussed possible mechanisms involved in COVID-19 TE. Case...

... and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Alopecia Hair loss Alopecia areata Vitiligo Autoimmune Melanogenesis Alopecia areata (AA) results from...

... or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Familial frontal fibrosing alopecia Trichology Hair loss Scarring...

... the relationship between smoking, PHG, and alopecia (androgenetic alopecia and frontal fibrosing alopecia). The prevalence of hair loss and PHG is more prevalent in smokers than nonsmokers. Smoking is associated with negative effects on hair health as evidenced in PHG and alopecia. Smoking status should...

..., instructions or products referred to in the content or advertisements. Klinefelter syndrome Alopecia Hair loss Testosterone Finasteride Testosterone is the main circulating androgen. The tissue effects of testosterone are mediated by binding of testosterone to the intracellular androgen receptor...

... in vismodegib-induced alopecia. Trichoscopy and confocal microscopy are essential to monitoring vismodegib hair loss and the response to the treatment. milenacappello@gmail.com 10 04 2020 6 07 2020 9 9 2020 © 2020 S. Karger AG, Basel 2020 Copyright / Drug Dosage / Disclaimer...